Emami Ltd logo

Emami Ltd

EMAMILTD NSE

Key Fundamentals

SmallcapPersonal CareConsumer Goods
Market Cap
₹17,390 Cr
Volatility
Moderate
P/E Ratio
23.36
EBITDA
₹1,049 Cr
Return on Equity
26.53%
Debt to Equity
0.06
Book Value
₹66.99
EPS
₹17.04
52W High
₹634.2
52W Low
₹376.4

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Emami Ltd insights

66 extracted metrics + investor summaries across FY11–FY26.

Log in — free

Tapetide Score

Data-driven rating, 0–100. How it works →

Technical Indicators

Key Insights

Strengths

4
  • Company is almost debt free.
  • Company has a good return on equity (ROE) track record: 3 Years ROE 28.5%
  • Company has been maintaining a healthy dividend payout of 52.9%
  • Debtor days have improved from 42.3 to 33.2 days.

Weaknesses

2
  • The company has delivered a poor sales growth of 5.58% over past five years.
  • Tax rate seems low

Growth Rate

Revenue Growth
-0.33% ↘
Net Income Growth
-3.41% ↘
Cash Flow Change
-10.64% ↘
ROE
-10.97% ↘
ROCE
-12.81% ↘
EBITDA Margin (Avg.)
-3.76% ↘

AI Analysis — Bull vs Bear

Anthropic anthropic claude-opus-4.6 5d ago
AI opinion · based on fundamentals
Risk medium

Emami Ltd is a nearly debt-free FMCG company with a market cap of ₹17,314 Cr trading at a PE of 23.1x. It has delivered a consistent 3-year ROE of 28% and maintains a healthy dividend payout of 52.9%, but faces headwinds from sluggish revenue growth (5-year sales CAGR of just 6%) and a sharp stock price decline of 32% over the past year.

Bull Case 7
  • Company is virtually debt-free, providing significant financial flexibility and low interest burden
  • Strong return on equity track record with 3-year ROE of 28% and 5-year ROE of 31%, indicating efficient capital allocation
  • Healthy dividend payout ratio of 52.9% with a current dividend yield of 2.52%, offering meaningful income to shareholders
  • Improvement in debtor days from 42.3 to 33.2 days, reflecting better working capital management and collection efficiency
  • Compounded profit growth of 11% over 5 years outpaces sales growth, suggesting margin expansion and cost discipline
  • Price-to-book ratio of 5.93x is reasonable for a debt-free FMCG company with 28%+ ROE, implying valuation is not stretched relative to return profile
  • 10-year ROE average of 26% demonstrates long-term consistency in generating shareholder returns across business cycles
Bear Case 8
  • Stock price has declined 32% over the past 1 year significantly underperforming broader markets, indicating persistent selling pressure
  • Revenue growth remains sluggish with 5-year compounded sales CAGR of only 6% and TTM sales growth decelerating to just 3%
  • TTM compounded profit has declined by 7%, signaling near-term earnings pressure despite longer-term growth
  • Negative stock CAGR across all timeframes — 3-year at -8%, 5-year at -7%, and 10-year at -4% — reflecting sustained value destruction for shareholders
  • 3-year compounded sales growth of only 4% suggests the company is struggling to grow its topline even in a recovering consumer demand environment
  • Low effective tax rate raises questions about sustainability of reported earnings if tax benefits expire or normalize
  • 10-year compounded sales CAGR of just 5% indicates structural limitations in scaling the business or expanding addressable market
  • Despite strong ROE and profitability metrics, the market has consistently de-rated the stock over 10 years (stock CAGR -4%), suggesting investors see limited growth runway

This is AI-generated analysis, not financial advice. Do your own due diligence.

AI News Digest

Anthropic anthropic claude-opus-4.6 17h ago
Headwinds 4
  • Q1 PAT down 16% YoY Aug 4

    Net profit fell 16% YoY to ₹137 crore in Q1FY27 due to higher input costs and tax expenses, despite 15% revenue growth.

  • Auditor qualified conclusion Aug 4

    Statutory auditors issued a qualified conclusion on Q1FY26 results due to unreviewed subsidiary financials following Axiom Ayurveda and IncNut Digital acquisitions.

  • Kesh King mid-single-digit growth Aug 5

    Kesh King posted only mid-single-digit growth in Q1, though management targets double-digit growth by year-end.

  • Tax rate rising to 25-26% Aug 5

    Effective tax rate expected at 25-26% for the current fiscal year following the end of fiscal benefits, pressuring bottom line.

Positives 5
  • Revenue up 15% to ₹1,039 Cr Aug 4

    Consolidated revenue rose 15% YoY to ₹1,039 crore in Q1FY27 driven by strong domestic growth.

  • Strategic portfolio up 61% Aug 5

    Strategic investment portfolio posted 61% growth in Q1, with management viewing this as sustainable for the rest of the year.

  • 10.5% emission reduction FY26 Jul 30

    Emami achieved a 10.5% reduction in Scope 1 and 2 emissions, plastic neutrality, and 90% sustainable packaging in FY26.

  • Promoter releases pledged shares Aug 12

    Diwakar Finvest and Suraj Finvest each released 5,000 shares from pledge with Standard Chartered Capital, signalling improving promoter comfort.

  • International growth expected H2 Aug 5

    International business set for strong growth in Q3 and Q4 driven by strategic changes, with pricing adjustments expected to offset input cost pressures.

Neutral 3
  • ₹21 Cr block trade on NSE Jul 21

    Approximately 5.24 lakh shares traded in a block deal at ₹403.55 per share totalling ₹21.15 crore, indicating institutional activity.

  • 43rd AGM on August 25 Jul 27

    Emami scheduled its 43rd AGM for August 25, 2026 via video conferencing with e-voting from August 20-24.

  • Q1 earnings call audio released Aug 4

    Emami published the audio recording of its analyst conference call for unaudited Q1 results ended June 30, 2026.

TL;DR: Emami delivered strong 15% top-line growth in Q1FY27 and its strategic portfolio surged 61%, but profitability took a hit with PAT declining 16% due to input cost inflation and a higher tax rate. Kesh King underperformed in Q1 though management guides to double-digit growth by year-end. The revenue trajectory and international expansion plans are encouraging, but margin headwinds from rising costs and tax normalization remain key risks to monitor over the next two quarters.

Quarterly Results

  Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
826
865
996
891
906
891
1,049
963
904
799
1,152
925
1,039
Expenses
636
632
682
682
692
645
715
744
692
622
768
739
815
Operating Profit
190
233
314
209
214
246
334
219
212
177
384
186
225
OPM %
23%
27%
32%
24%
24%
28%
32%
23%
23%
22%
33%
20%
22%
Other Income
8
11
11
11
10
22
15
21
22
21
9
23
18
Interest
2
2
3
3
2
2
2
3
2
3
3
3
6
Depreciation
46
46
46
48
44
45
46
44
44
45
45
42
43
PBT
150
196
276
169
178
220
301
194
187
150
345
164
195
Tax %
9%
8%
6%
13%
16%
4%
7%
16%
12%
1%
7%
13%
29%
Net Profit
137
180
261
147
151
211
279
162
164
148
319
143
139
EPS in Rs
3.14
4.09
5.92
3.41
3.5
4.87
6.39
3.72
3.76
3.4
7.32
3.28
3.15
Figures in ₹ Crores

Profit & Loss

  Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
2,076
2,358
2,488
2,531
2,695
2,655
2,881
3,192
3,406
3,578
3,809
3,780
3,915
Expenses
1,536
1,670
1,729
1,812
1,970
1,970
2,000
2,254
2,550
2,632
2,796
2,820
2,943
Operating Profit
541
688
759
719
725
685
880
938
855
946
1,014
960
972
OPM %
26%
29%
31%
28%
27%
26%
31%
29%
25%
26%
27%
25%
25%
Other Income
91
44
31
19
25
46
69
90
69
41
68
75
72
Interest
5
54
58
34
21
21
13
5
7
10
9
11
14
Depreciation
34
255
309
311
325
336
367
335
247
186
178
177
176
PBT
592
423
424
393
403
374
569
688
670
791
894
846
854
Tax %
18%
14%
20%
22%
25%
19%
20%
-22%
6%
8%
10%
8%
—
Net Profit
485
363
340
306
303
302
455
837
627
724
803
775
750
EPS in Rs
10.7
8
7.5
6.77
6.68
6.67
10.23
19.02
14.5
16.58
18.48
17.76
17.15
Div. Payout %
33%
44%
47%
52%
60%
60%
78%
42%
55%
48%
54%
56%
—
Figures in ₹ Crores

Balance Sheet

  Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
23
23
23
23
45
45
44
44
44
44
44
44
Reserves
1,208
1,589
1,732
1,991
2,031
1,778
1,718
2,032
2,259
2,403
2,651
2,880
Borrowings
36
671
473
326
110
210
101
282
91
94
90
162
Other Liabilities
410
409
376
458
633
644
656
692
703
728
741
745
Total Liabilities
1,676
2,692
2,603
2,798
2,819
2,678
2,520
3,050
3,096
3,269
3,525
3,831
Fixed Assets
453
1,918
1,994
1,802
1,680
1,459
1,132
1,344
1,245
1,114
984
886
CWIP
29
67
22
30
36
8
6
3
6
8
15
1
Investments
501
104
128
314
187
156
255
303
293
442
676
834
Other Assets
693
604
460
652
915
1,055
1,126
1,400
1,551
1,706
1,850
2,108
Total Assets
1,676
2,692
2,603
2,798
2,819
2,678
2,520
3,050
3,096
3,269
3,525
3,831
Figures in ₹ Crores

Cash Flow

  Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
534
562
730
588
554
531
922
644
749
779
896
801
Investing
-237
-1,313
-306
-276
-26
-231
-224
-234
-122
-210
-345
-174
Financing
-215
502
-496
-324
-428
-405
-688
-402
-608
-563
-500
-554
Net Cash Flow
82
-249
-72
-12
100
-106
9
8
19
6
52
72
Free Cash Flow
426
430
448
465
421
383
890
164
719
750
852
770
CFO/OP
116
96
105
93
89
89
115
84
101
98
107
101
Figures in ₹ Crores

Ratios

  Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
18
20
14
22
29
42
29
37
44
50
43
33
Inventory Days
59
68
83
87
88
102
118
121
100
102
94
128
Days Payable
90
112
85
109
115
135
138
138
124
143
133
153
Cash Conversion Cycle
-13
-24
12
1
2
9
10
19
20
9
4
8
Working Capital Days
-16
-54
-62
-32
-6
7
-3
0
28
30
25
21
ROCE %
61%
30%
23%
22%
19%
18%
29%
31%
28%
32%
32%
28%

Shareholding Pattern

As of Jun 2026
Promoters 54.84%
DIIs 27.01%
FIIs 7.87%
Public 5.76%
Others 4.51%
Total 99.99%
  Mar 2021Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoters
53.86%
53.86%
53.86%
53.86%
54.27%
54.27%
54.27%
54.27%
54.27%
54.52%
54.84%
54.84%
54.84%
54.84%
54.84%
54.84%
54.84%
54.84%
54.84%
54.84%
54.84%
54.84%
FIIs
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
13.46%
14.02%
14.38%
14.11%
12.11%
11.89%
10.93%
9.03%
8.58%
7.87%
DIIs
23.09%
22.23%
23.65%
25.42%
24.28%
26.45%
26.99%
27.02%
26.92%
26.20%
25.22%
23.77%
22.07%
21.61%
21.51%
21.70%
23.67%
24.06%
25.01%
26.73%
26.92%
27.01%
Government
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
Public
4.60%
4.34%
4.18%
4.03%
4.00%
3.93%
3.75%
3.86%
4.05%
3.60%
3.90%
4.01%
4.74%
4.84%
4.93%
5.40%
5.38%
5.30%
5.26%
5.37%
5.62%
5.76%
Others
18.46%
19.57%
18.32%
16.70%
17.45%
15.35%
14.99%
14.85%
14.76%
15.68%
16.05%
17.38%
4.89%
4.69%
4.34%
3.95%
4.00%
3.89%
3.95%
4.03%
4.04%
4.51%
No. of Shareholders
0
82,090
81,508
82,193
83,257
86,242
89,971
85,460
90,285
89,955
79,216
82,151
91,334
97,258
1,27,897
1,28,725
1,29,002
1,26,599
1,26,776
1,29,077
1,27,615
1,31,617

Documents

Frequently Asked Questions about Emami Ltd

What does Emami Ltd do?
Emami is engaged in manufacturing & marketing of personal care & healthcare products with an enviable portfolio of household brand names such as BoroPlus, Navratna, Fair and Handsome, Zandu Balm, Kesh King, Zandu Pancharishta, Mentho Plus Balm and others.(Source : 201903 Annual Report Page No: 193)
Where is Emami Ltd (EMAMILTD) listed?
Emami Ltd is listed on the Indian stock exchanges. It is listed on NSE: EMAMILTD and BSE: 531162. You can view its live share price, financials, and ratios on Tapetide.
Which sector does Emami Ltd belong to?
Emami Ltd operates in the Consumer Goods sector within the Personal Care industry. Sector classification helps investors compare companies affected by similar economic conditions and regulatory changes.
What is the market capitalisation of Emami Ltd?
Emami Ltd has a market capitalisation of approximately ₹17390.16 Cr. Based on this, it is classified as a Mid Cap stock.
What is the PE ratio of Emami Ltd?
The Price-to-Earnings (PE) ratio of Emami Ltd is 23.36. The PE ratio compares a company's share price to its earnings per share and is commonly used to assess whether a stock is overvalued or undervalued relative to its peers.
What is the 52-week high and low of Emami Ltd?
Over the past 52 weeks, Emami Ltd has traded between a low of ₹376.4 and a high of ₹634.2. This range helps investors understand the stock's price volatility and recent trading levels.
Does Emami Ltd pay dividends?
Yes, Emami Ltd has a dividend yield of 2.47%. Dividend yield indicates the annual dividend income relative to the share price. A consistent dividend history can signal financial stability.
What is the Return on Equity (ROE) of Emami Ltd?
Emami Ltd has a Return on Equity (ROE) of 26.53%. ROE measures how effectively a company uses shareholders' equity to generate profits. A higher ROE generally indicates better capital efficiency.
How can I research Emami Ltd on Tapetide?
On Tapetide, you can view Emami Ltd's live share price, quarterly results, profit & loss statements, balance sheet, cash flow, key ratios, shareholding pattern, technical indicators, analyst ratings, and forecasts — all on a single page without needing to sign up.

Company Information

Emami is engaged in manufacturing & marketing of personal care & healthcare products with an enviable portfolio of household brand names such as BoroPlus, Navratna, Fair and Handsome, Zandu Balm, Kesh King, Zandu Pancharishta, Mentho Plus Balm and others.(Source : 201903 Annual Report Page No: 193)

Website emamiltd.in
CEO Mr. Radhe Shyam Goenka B.Com., L.L.B., M.Com. LLB
Employees 3,217
Listed 2006-08-03
Face Value ₹ 1
Issued Size 43,65,00,000

Explore More

More in Consumer Goods → FII DII Data Stock Screener Nifty 50 Heatmap F&O Ban List